Latigo Biotherapeutics Inc. (LTGO) Max Pain Analysis
Max pain is the strike price where aggregate option buyer payout is minimized at expiration. It represents the price at which option writers retain the most premium.
Latigo Biotherapeutics Inc. (LTGO) operates in the Healthcare sector, specifically the Medical - Pharmaceuticals industry, with a market capitalization near $1.46B, listed on NASDAQ, employing roughly 59 people, carrying a beta of 0.00 to the broader market. Latigo Biotherapeutics, Inc. Led by Nima Farzan, public since 2026-08-07.
Max pain analysis shows the strike price where the most options expire worthless. No recent options activity for LTGO as of 2026-08-31; this typically reflects low options liquidity, a recently listed name, or a temporary data feed delay. Snapshot will refresh on the next active session.